[Infostock Daily=Reporter Park Jeong-Do] From December this year, food safety management certification standards (HACCP) will be mandatory for children's favorite foods such as snacks and candy. In addition, the labeling system for all ingredients of medicines, which lists the names of all ingredients in medicines containers and packaging items, will be implemented in earnest from July.
In the situation where Covid-19 is prolonged, it is also required to wear masks for food manufacturers and to have hand disinfectants at restaurants.
The Korea Food and Drug Administration (KFDA) announced its "Major Food and Drug Policy for the Second Half of the Year" and introduced future policies.
First, a total of eight foods, including confectionery, candy, bread, rice cake, and chocolate, will be mandatory for HACCP from December this year. Health functional foods are also mandatory to apply GMP for pharmaceutical manufacturing and quality control standards.
In the case of livestock processing and edible eggs, selective packaging companies must obtain HACCP certification before the business license from October and receive re-certification every three years.
Experiments on residual substances such as antibiotics and pesticides of crude oil, which are dairy raw materials such as milk, will be conducted in July, followed by the private sector. Dairy exporting countries must submit the results of antibiotics and other residue tests to the Korean government from December.
The KFDA will make it mandatory to wear masks for food manufacturers and other food disinfectants.
In the field of medicines, the entire ingredient labeling system will be implemented in July to meet the right of the public to know and to strengthen the transparent disclosure of information. The information on bundles of generic drugs (copys and pharmaceuticals) will be gradually disclosed through the website of the Pharmaceutical Safety Country from August so that the public can easily know.
In addition, on August 28, a customized management system will be implemented, such as establishing a management business such as human cells in accordance with the implementation of the Advanced Renewal Bio Law, and requiring long-term follow-up of patients with medication. It also strengthens safety management of advanced biopharmaceuticals such as gene therapy.
In May, the medical device sector will also be in full swing, with the implementation of the Medical Device Industry Promotion and Innovation Medical Device Support Act, and new systems such as designation of innovative medical devices and special licensing and licensing will be in full swing. It is mandatory to report the supply of medical devices to manufacturing, importing, selling, and leasing companies supplying medical devices to medical institutions through an integrated information system from July.
Reporter Park Jeong-Do newface0301@naver.com
